Abiopharma

Clinical trial NCT05489705: enrollment: 1600 → 1700 participants.

Clinical trial NCT07471477 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-06-06 3. primary completion date: 2026-06-01 → 2026-06-06 4. enrollment: 60 → 56 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06431022 updates: 1. completion date: 2026-05-10 → 2026-06-05 2. primary completion date: 2026-05-10 → 2026-06-05

Clinical trial NCT07578649: collaborators added: European Network of Gynaecological Oncological Trial Groups (ENGOT).

Clinical trial NCT02232516 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-08-01 → 2024-03-16

Clinical trial NCT07248839 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-04-06 → 2026-08-05 3. primary completion date: 2026-04-06 → 2026-08-05

Clinical trial NCT07176507 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-10-01 → 2025-10-30

Clinical trial NCT05933525: enrollment: 60 → 63 participants.

Clinical trial NCT07532213 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-23 → 2026-04-13

Clinical trial NCT05742750 updates: 1. status: UNKNOWN → COMPLETED 2. start date: 2023-03-01 → 2023-04-27 3. completion date: 2024-12-30 → 2026-05-30 4. primary completion date: 2023-12-30 → 2025-12-01 5. enrollment type: ESTIMATED → ACTUAL